AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 126 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,299 | -88.8% | 3,025 | -80.6% | 0.00% | -83.3% |
| Q2 2023 | $172,672 | +169186.3% | 15,570 | +134.5% | 0.01% | +100.0% |
| Q1 2023 | $102 | -74.5% | 6,640 | -63.1% | 0.00% | -82.4% |
| Q4 2022 | $400 | -99.8% | 18,002 | +75.0% | 0.02% | +466.7% |
| Q3 2022 | $168,000 | +5.0% | 10,286 | -6.6% | 0.00% | -25.0% |
| Q2 2022 | $160,000 | +515.4% | 11,013 | +690.6% | 0.00% | – |
| Q1 2022 | $26,000 | -75.5% | 1,393 | -68.8% | 0.00% | -100.0% |
| Q4 2021 | $106,000 | +341.7% | 4,460 | +364.6% | 0.00% | +100.0% |
| Q3 2021 | $24,000 | -85.0% | 960 | -85.2% | 0.00% | -75.0% |
| Q2 2021 | $160,000 | +416.1% | 6,474 | +356.6% | 0.00% | +300.0% |
| Q1 2021 | $31,000 | +6.9% | 1,418 | +26.8% | 0.00% | 0.0% |
| Q4 2020 | $29,000 | -60.8% | 1,118 | -57.5% | 0.00% | 0.0% |
| Q3 2020 | $74,000 | – | 2,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |